Anaptysbio, Inc SEC filings ANAB

Anaptysbio, Inc has 725 filings in SEC EDGAR's recent list, going back to Jul 6, 2006. Its latest annual report, Form 10-KT, was filed on Sep 21, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026. The company's fiscal year ends on June 30.

Anaptysbio, Inc SEC filings
Form Description Filed Period
4 Insider transaction Oct 2, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
10-KT Transition report Sep 21, 2026 Jun 30, 2026
8-K Current report Sep 21, 2026 Sep 21, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Shareholder vote results
Aug 11, 2026 Aug 11, 2026
4 Insider transaction Aug 7, 2026 Mar 12, 2026
4 Insider transaction Aug 7, 2026 Mar 12, 2026
8-K Current report
Regulation FD disclosure
Jul 30, 2026 Jul 28, 2026
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
ARS Annual report to shareholders Jun 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 29, 2026 —
DEF 14A Proxy statement Jun 29, 2026 Jun 29, 2026
144 Notice of proposed sale Jun 26, 2026 —
8-K Current report
Material agreement
Jun 22, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 17, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 9, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 5, 2026 —
144 Notice of proposed sale Jun 5, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
8-K Current report
Regulation FD disclosure
May 29, 2026 May 29, 2026
144 Notice of proposed sale May 29, 2026 —
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 27, 2026 —
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 22, 2026 —
8-K Current report
Bylaw or fiscal year change
May 21, 2026 May 18, 2026
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 13, 2026 May 11, 2026
3 Initial insider ownership May 13, 2026 May 11, 2026
4 Insider transaction May 13, 2026 May 11, 2026
3 Initial insider ownership May 13, 2026 May 11, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Officer or director change
May 11, 2026 May 11, 2026
4 Insider transaction Apr 29, 2026 Apr 27, 2026
10-K/A Amended annual report Apr 28, 2026 Dec 31, 2025
8-K/A Amended current report Apr 24, 2026 Apr 20, 2026
4/A Filing Apr 23, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Other events
Apr 20, 2026 Apr 20, 2026
3 Initial insider ownership Apr 3, 2026 Mar 26, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
3 Initial insider ownership Apr 1, 2026 Apr 1, 2026
144 Notice of proposed sale Mar 30, 2026 —
4 Insider transaction Mar 27, 2026 Mar 25, 2026
8-K Current report
Material agreement, Agreement ended, Officer or director change, Regulation FD disclosure
Mar 27, 2026 Mar 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 3, 2026 Mar 3, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
144 Notice of proposed sale Feb 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 16, 2026 —
4 Insider transaction Jan 16, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 15, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2026 Jan 9, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Jan 6, 2026 Jan 3, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 6, 2026 Jan 3, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 6, 2026 Jan 3, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 6, 2026 Jan 3, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
144 Notice of proposed sale Dec 23, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 18, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 16, 2025 —
144 Notice of proposed sale Dec 16, 2025 —
8-K Current report
Regulation FD disclosure
Nov 26, 2025 Nov 26, 2025
8-K Current report
Other events
Nov 21, 2025 Nov 21, 2025
8-K Current report
Other events
Nov 21, 2025 Nov 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Regulation FD disclosure
Oct 14, 2025 Oct 14, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
144 Notice of proposed sale Sep 30, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Sep 29, 2025 Sep 29, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 23, 2025 —
4 Insider transaction Sep 17, 2025 Sep 15, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
144 Notice of proposed sale Aug 8, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2025 —
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jul 3, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
144 Notice of proposed sale Jun 18, 2025 —
144 Notice of proposed sale Jun 18, 2025 —
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 6, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
4 Insider transaction Mar 27, 2025 Mar 25, 2025
8-K Current report
Other events
Mar 24, 2025 Mar 24, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 7, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Regulation FD disclosure
Feb 19, 2025 Feb 19, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Feb 12, 2025 Feb 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Feb 3, 2025 Jan 31, 2025
4 Insider transaction Jan 15, 2025 Jan 13, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 2, 2025 Dec 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANAB (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1370053
Former names
ANAPTYSBIO INC (until Jun 12, 2019); ANAPTYS BIOSCIENCES INC (until Nov 20, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.